Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen to Pay up to $17.6M for Protein-Prep Assets of LumiCyte, SuNyx

NEW YORK, Aug. 1 (GenomeWeb News) - Qiagen said today that it plans to acquire assets from LumiCyte and SuNyx, two firms providing protein sample-preparation technology for MALDI mass spectrometry.


Qiagen will pay up to $16 million for "key assets" from LumiCyte, including its Surface Tension Segmented biochips for MALDI mass spectrometry. Initially, Qiagen will pay $3 million in cash, followed by $4 million after 18 months and $5 million after 30 months, depending on whether financial targets are met. In addition, Qiagen may make a milestone payment of $4 million after 60 months.


SuNyx provides two sample-preparation platforms for liquid chromatrography MALDI mass spectrometry called MPep  and MProtChip. Qiagen will pay up to $1.6 million in total for these assets, $800,000 initially and another $800,000 depending on certain milestones.


Qiagen said it will provide further details on the acquisitions in its second-quarter earnings conference call on Aug. 9.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.